Article

The Role of the Biomanufacturing Industry in Developing Diagnostics and mRNA Vaccines Against COVID-19

2026-01-19

Abstract excerpt

COVID-19, caused by the new type of coronavirus SARS-CoV-2, has put an unprecedented impact on health, economy and social areas around the globe. It created an urgent global need for rapid diagnostics, effective therapeutics, and scalable vaccine manufacturing. The biomanufacturing industry played a central role in meeting this challenge by accelerating the development, production, and distribution of SARS‑CoV‑2 d...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4e7abf79-34d6-59ce-a39b-bd1eb8f81f7e
DOI: 10.20944/preprints202601.1387.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The Role of the Biomanufacturing Industry in Developing Diagnostics and mRNA Vaccines Against COVID-19DOI 10.20944/preprints202601.1387.v1Read

The Role of the Biomanufacturing Industry in Developing Diagnostics and mRNA Vaccines Against COVID-19Semantic proximity Read

From COVID-19 to Global Health: Challenges and Opportunities in mRNA Vaccine ProductionSemantic proximity Read

mRNA Vaccines: Design Principles, Mechanisms, and Manufacturing—Insights From COVID‐19 as a Model for Combating Infectious DiseasesSemantic proximity Read

mRNA Vaccines Five Years After COVID-19: Lessons in Platform Design, Real-World Effectiveness, and EquitySemantic proximity Read

Enabling mRNA Therapeutics: Current Landscape and Challenges in ManufacturingSemantic proximity Read

Advancing mRNA vaccines for infectious diseases: key components, innovations, and clinical progressSemantic proximity Read

mRNA Vaccine Platforms and Lipid Nanoparticle Delivery Systems: Molecular Advances, Clinical Breakthroughs, and Regulatory Perspectives (2020–2025)Semantic proximity Read

Platforms, advances, and technical challenges in virus-like particles-based vaccinesSemantic proximity Read

Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2Semantic proximity Read

Elasomeran (mRNA1273) Vaccine: The Journey from Preclinical Research to Clinical Trials, Authorization, and FDA ApprovalSemantic proximity Read

The Unique Features and Collateral Immune Effects of mRNA-Based COVID-19 Vaccines: Potential Plausible Causes of Adverse Events and ComplicationsSemantic proximity Read

Antigen Delivery Platforms for Next-Generation Coronavirus Vaccines: The Superiority of Nucleoside-Modified mRNA Encapsulated in Lipid Nanoparticles Vaccine PlatformSemantic proximity Read